Biotron appoints Glenn Gilbert as CEO

SYDNEY: Biotron Limited (ASX: BIT) announced Wednesday the appointment of Glenn Gilbert as chief executive officer and executive director, effective Jan. 18, 2027. Gilbert, an ASX-experienced healthcare executive with more than 20 years in the pharmaceutical, medical device and in-vitro…